ESC Premium Access

Panel discussion - PSCK9 inhibition: a new horizon in LDL-C management.

logo

Congress Presentation

About the speakers

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

Professor Alberico Catapano

IRCCS - MultiMedica, Milan (Italy)
47 presentations
3 followers

Doctor Jennifer Robinson

University of Iowa, Iowa (United States of America)
12 presentations
0 follower

2 more presentations in this session

Introduction - PSCK9 inhibition: a new horizon in LDL-C management.

Speaker: Professor A. Catapano (Milan, IT) Doctor J. Robinson (Iowa, US) Professor C. Cannon (Boston, US)

Thumbnail

Identifying appropriate patients to treat: clinical cases and evidence discussion.

Speaker: Doctor J. Robinson (Iowa, US)

Thumbnail

Access the full session

PSCK9 inhibition: a new horizon in LDL-C management

Speakers: Professor C. Cannon, Professor A. Catapano, Doctor J. Robinson, Professor A. Catapano, Doctor J. Robinson...
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by